Sandoz Gets Approval For US Pegfilgrastim

Becomes First To Offer Both Long- And Short-Acting Biosimilars

 
• By Akriti Seth
  
Paper_Planes
Sandoz will become the only company in US to offer both long- and short-acting filgrastim biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products